TAK Research and Charts

TAK - Takeda Pharmaceutical Co Ltd ADR (Healthcare: Drug Manufacturers - Specialty & Generic)

Projected Earnings Date: 0000-02-29 (Delayed quote data 2026-02-10)

Last 18.10	Change ⇑ +0.37 (+2.09%)	Volume 2,128,337
	Open 18.00	High 18.16	Low 17.98

8EMA (Daily) 17.64	40EMA (Daily) 16.36	50EMA (Daily) 16.12	STO (Daily) 94.041	MACD Hist (Daily) 0.050
8EMA (Weekly) 16.773	40EMA (Weekly) 15.20	50EMA (Weekly) 15.05	STO (Weekly) 96.245	MACD Hist (Weekly) 0.383


Company Profile
Takeda Pharmaceutical is Japan?s largest pharmaceutical company, with revenue of JPY 3.3 trillion in 2019. The company?s five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 70% of revenue. Its geographic footprint is well diversified, with 50% derived from the U.S., 20% from Japan, 20% from Europe and Canada.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.